PLPCPlatform

PLPC™ Platform is a global-ready, non-pharmacodynamic immunobiological architecture enabling scalable, traceable, and modular precision oncology.

[PLPCPlatform @PLPC_DB]

#PLPCPlatform
#PrecisionImmunotherapy
#CancerImmunotherapy
#PrecisionMedicine
#Biotech
#OncologyResearch
#Immunology
#BiomedicalInnovation

[PLPCPlatform @PLPC_DB]

Discover more: https://t.co/kJE3zFsmUO

#PLPCPlatform #Biotech #PrecisionMedicine

[PLPCPlatform @PLPC_DB]

PLPC Platform advances functional ex vivo stratification for phospholipoproteomic formulations, enabling traceable preclinical evaluation and structured biological response analysis.

[PLPCPlatform @PLPC_DB]

Media coverage on translational oncology leadership:
🔗 https://t.co/U2IAEEmGhe

[PLPCPlatform @PLPC_DB]

What if cancer innovation were measured by biological coherence?

🔬 Validation
🧬 Immune architecture
📊 Sustainable outcomes
#PLPCPlatform #Oncology #Immunotherapy

[PLPCPlatform @PLPC_DB]

For more information:
https://t.co/mHTIHQo7Z6

[PLPCPlatform @PLPC_DB]

Ex vivo validation without systemic exposure.

Biomedicines (2025, IF≈3.9, PMID: 41007664) reports real-time kinetic imaging (IncuCyte® S3) + Functional Stratification Index (FSI) for batch comparability and regulatory-aligned documentation.
DOI open access.
#PLPC #Immunotherapy

[PLPCPlatform @PLPC_DB]

For more information:
https://t.co/xSmkIk9o4g

[PLPCPlatform @PLPC_DB]

PLPC-DB™ preclinical upgrade.

Biology 2025 (PMID:40906111) validates a label-free kinetic platform capturing tumor proliferation, death rates & IFN-γ/IL-10 shifts.

FSI enables reproducible response stratification.
Neutral ex vivo conditions.
#PrecisionOncology #Biotech

[PLPCPlatform @PLPC_DB]

For more information:
https://t.co/jXmxEsSyCR

[PLPCPlatform @PLPC_DB]

STIP: Structured Immunophenotypic Traceability Platform.

Published in Int. J. Mol. Sci. (2025, IF≈4.9, PMID:40564910).

Flow cytometry + CBA + WB for CD69/CD25 activation, Th1/Th2/Th17 profiling & vesicle integrity.
Regulatory-compatible monitoring for PLPC-DB™.
#Oncology

[PLPCPlatform @PLPC_DB]

For more information:
https://t.co/yRYG3GOZb8

[PLPCPlatform @PLPC_DB]

Cancers (2025): Introduction of an ultrapurified phospholipoproteic complex (PLPC) as a scalable alternative to conventional exosomes.

PubMed-indexed validation of structural stability and immunomodulatory potential.

#Biotech #Immunotherapy

[PLPCPlatform @PLPC_DB]

For more information:
https://t.co/u74TMIPDcg

[PLPCPlatform @PLPC_DB]

PLPC-DB™ validated in Biomedicines (2025).
PMID: 40564018 | DOI: 10.3390/biomedicines13061299
400 proteins across conditions.
90% immune markers preserved post-cryopreservation.
PCA & volcano plots confirm stability.
Built for scalable precision immunotherapy.
#PLPC_DB #Oncology

[PLPCPlatform @PLPC_DB]

For more information:
https://t.co/1PPBoAAOKL

[PLPCPlatform @PLPC_DB]

PLPC-DB™ (2025) is supported by five PubMed-indexed publications validating structural stability, immune preservation, and functional monitoring.

A scalable, non-cellular platform for precision immunotherapy.

#Biotech #Immunotherapy

[PLPCPlatform @PLPC_DB]

What happens before diagnosis matters.

PLPC-DB targets early immune imbalance through selective modulation.

Ex vivo PBMC data:
↑ IFN-γ | ↓ IL-10
Th1 polarization
Selective tumor apoptosis
Structured immunotherapy builds resilience.
#PLPCDB #Immunotherapy

[PLPCPlatform @PLPC_DB]

The diagnosis is not only clinical — it is structural.

When medicine treats without teaching the immune system, responses are temporary.

PLPC DB is built on immune education:
• High efficacy
• Low toxicity
• Durable response
Precision is not just targeting. It is training.